Date: 2015-06-02
Type of information: Nomination
Compound:
Company: Amag Pharmaceuticals (USA - MA)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On June 2, 2015, Amag Pharmaceuticals announced two appointments to its senior management team. Julie Krop, M.D., has joined the company as chief medical officer and senior vice president, clinical development and regulatory affairs, and Audrey Wu as vice president of commercial strategy and marketing for the company\'s maternal health business. Dr. Krop brings more than 15 years of experience in drug development, working with clinical teams in the strategic design and execution of development plans, and leading the preparation and participation in pre-approval FDA advisory panel presentations and discussions. In addition, she has worked with the FDA and European Medicines Agency (EMEA) to obtain drug approvals in the U.S. and Europe. She joins Amag from Vertex Pharmaceuticals, where she most recently served as vice president, clinical development. Dr. Krop began her career in clinical research in 1991 at Pfizer Pharmaceuticals and has since held various leadership positions at Stryker Regenerative Medicine, Peptimmune, and Millennium Pharmaceuticals. Dr. Krop received her bachelor\'s degree from Brown University and her medical degree from the Brown University School of Medicine. She completed her residency in the Department of Medicine at Georgetown University Hospital and a fellowship in the Department of Endocrinology at the Johns Hopkins University School of Medicine. In addition, Dr. Krop was a Robert Wood Johnson Foundation Clinical Scholar. Ms. Wu has 13 years of dedicated industry experience in both new and commercialized product planning, including marketing management, corporate rebuilding and rebranding, and public affairs and advocacy. She has been a marketing strategy consultant for the past two years, partnering with clients in women\'s health, virology, and pulmonology to develop and implement market-winning brand and therapeutic area strategies. Prior to that, Ms. Wu led the marketing team at Ther-Rx (a predecessor company to Lumara Health, which Amag acquired in November 2014). Ms. Wu received a bachelor\'s of science in chemical engineering from Massachusetts Institute of Technology and a master\'s of business administration from the University of Michigan at Ann Arbor.
Financial terms:
Latest news:
